Individualized treatment of osteoporosis

被引:0
|
作者
Harbeck, B. [1 ]
Lehnert, H. [2 ]
机构
[1] Univ Lubeck, Med Klin 1, Univ Klinikum Schleswig Holstein, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany
[2] Univ Lubeck, Prasidium, Lubeck, Germany
来源
INTERNIST | 2016年 / 57卷 / 07期
关键词
Osteoporosis; drug therapy; Age factors; Comorbidity; Risk assessment; Fracture prophylaxis; BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; BISPHOSPHONATES; DENOSUMAB; TERIPARATIDE; EFFICACY; ALENDRONATE; PREVENTION;
D O I
10.1007/s00108-016-0074-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is the most common clinical disorder of bone metabolism. Treatment decisions should be made on an individual basis, taking into consideration the relative benefits and risks in different patient populations. Drug selection should be based on the form (primary/secondary) and severity of osteoporosis, age, sex, the specific contraindications and precautions for using the various available medications, and existing comorbidities.
引用
收藏
页码:638 / +
页数:7
相关论文
共 50 条
  • [21] Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide
    Pleiner-Duxneuner, Johannes
    Zwettler, Elisabeth
    Paschalis, Eleftherios
    Roschger, Paul
    Nell-Duxneuner, Valerie
    Klaushofer, Klaus
    CALCIFIED TISSUE INTERNATIONAL, 2009, 84 (03) : 159 - 170
  • [22] Treatment of osteoporosis after alendronate or risedronate
    Eiken, P.
    Vestergaard, P.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 1 - 12
  • [23] Molecular understanding of pharmacological treatment of osteoporosis
    Tanaka, Sakae
    EFORT OPEN REVIEWS, 2019, 4 (04): : 158 - 164
  • [24] Bilateral Atypical Femoral Fractures after Bisphosphonate Treatment for Osteoporosis: A Literature Review
    Hwang, SeokJoon
    Seo, Minsu
    Lim, Dongin
    Choi, Min Suk
    Park, Jin-Woo
    Nam, Kiyeun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [25] A Comparison Between Bisphosphonates and Other Treatments for Osteoporosis
    Le Goff, B.
    Guillot, P.
    Glemarec, J.
    Berthelot, J. M.
    Maugars, Y.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (27) : 3037 - 3044
  • [26] An EDITOR Approach to Osteoporosis: A Review for Nurse Practitioners
    El Hussein, Mohamed Toufic
    Sheehan, Dawson S.
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (04):
  • [27] Individualized therapy for osteoporosis prevention and treatment in women under 60
    de Villiers, T. J.
    CLIMACTERIC, 2009, 12 (03) : 210 - 212
  • [28] The Effects of Trends in Osteoporosis Treatment on the Incidence of Fractures
    Horikawa, Akira
    Miyakoshi, Naohisa
    Hongo, Michio
    Kasukawa, Yuji
    Shimada, Yoichi
    Kodama, Hiroyuki
    Sano, Akihisa
    JOURNAL OF OSTEOPOROSIS, 2021, 2021
  • [29] The evolving role of anabolic therapy in the treatment of osteoporosis
    Cosman, Felicia
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (04) : 376 - 380
  • [30] Diagnosis and Treatment of Osteoporosis in Chronic Renal Disease
    Miller, Paul D.
    SEMINARS IN NEPHROLOGY, 2009, 29 (02) : 144 - 155